A large genetic screen has revealed how stem cells transform into brain cells, exposing hundreds of genes that make this ...

Genetic treatments could be the key to unlocking some rare diseases. But bringing these medicines to patients involves ...

Gene-editing technologies show great promise for medical treatments and research, with the potential to cure thousands of ...

Multiple sclerosis (MS) is a chronic neurological disease characterized by nerve damage and consequent impairments in vision, ...

A notable surge in investment activity has emerged around Intellia Therapeutics, with significant share acquisitions by both ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...

Crops increasingly need to thrive in a broader range of conditions, including drought, salinity, and heat. Traditional plant ...

The startup aims to create a platform for treating extremely rare genetic mutations, armed with CRISPR advances and new regulatory pathways.

If I were to locate the moment AI slop broke through into popular consciousness, I’d pick the video of rabbits bouncing on a ...

Scientists have discovered a new CRISPR mechanism with precise activity, expanding the potential applications of the existing ...

Co-founded by Jennifer Doudna and Fyodor Urnov, the company intends to simultaneously develop many gene editing treatments ...

The gene therapy success with Baby KJ, along with a new FDA program, have companies more interested in treating rare disease.